- 01
Ames B. N..
Micronutrients prevent cancer and delay aging.
Toxycology Letters.
102
1998;
5-103
- 02
Anderson M. E., Powrie F., Puri R. N., Meister A..
Glutathione Monoethyl Ester: Preparation Uptakc by Tissues, and Conversion to glutathione.
Archives of Biochemistry and Biophysics.
239
(2)
1985;
538-548
- 03 Arndt K., Albers T.. Handbuch Protein und Aminosäuren. Novagenics Verlag Arnsberg;
2001
- 04
Arnold-von Versen B..
Der Einsatz von Mikronährstoffen bei Tumorerkrankungen und zur Tumorprävention.
Deutsche Zeitschrift für Onkologie.
33
2001;
19-29
- 05
Baldew G. S., van den Hamer C. J. A., Los G., Vermeulen N. P. E., de Goeij J. J. M.,
McVie J. G..
Selenium induced protection against cis-Diamminedichloroplatinum (ii) Nephrotoxicity
in Mice and Rats.
Cancer Res.
49
1989;
3020-3023
- 06
Barbul A..
Arginine and immune function.
Nutrition.
6
1990;
53-58
- 07
Beuth J..
Komplementäre Maßnahmen in der Onkologie-Update 2001.
Deutsche Zeitschrift für Onkologie.
33
2001;
45-50
- 08
Biesalski H. K..
Vitamine in der Prävention von Krebserkrankungen.
Münch. med. Wschr.
138
(18)
1996;
315-320
- 09 Biesalski H. K.. Adjuvante Ernährungstherapie bei Tumorpatienten. Abstract. Medica
Baden Baden; 1996
- 10
Bitsch, R. R., Böhm V..
Vitamine und Mineralstoffe in der Prävention und Therapie von Krebs.
Onkologie.
1
1995;
555-561
- 11
Clark L. C., Combs G. F., Turnball B. W..
Effects of selenium supplementation for cancer prevention in patients with carcinoma
of the skin. A randomised controlled trial.
JAMA.
276
1996;
1957-1963
- 12 Cheng X., Xu G. L.. Effects of selenium on adriamycin induced cardiotoxicity in
mice. Abstract from the international Symposium Selenium in Biology and medicine.
Tuebingen; 1988
- 13
Daly J. M., Reynolds J., Thom A..
Immune and metabolic effects of arginine in their surgical patient.
Ann Surg.
208
1988;
512-523
- 14
Daly J. M., Reynolds J., Sigal R. K., Shou J., Liebermann M. D..
Effect of dietary protein and amino accids on immune function.
Crit Care Med.
18
1990;
86-93
- 15
Diamond A. M., Dale P., Murray J. L., Grdina D. J..
The inhibition of radiation induced mutagenesis by combined effects of selenium and
the amniothiol WR-1065.
Mutation Research.
356
1996;
147-154
- 16 Dietl H., Ohlenschläger G.. Handbuch der orthomolekularen Medizin. Karl F. Haug
Verlag Heidelberg; 1998
- 17
Dimitrov N. V., Charamella L. J., Meyer C. J., Stowe H. D., Ku P. K., Ullrey D. E..
Modulation of natural killer cell activity by selenium in humans.
J. nutr. Growth Cancer.
3
1986;
193-198
- 18
Doll, R. R., Petro R..
The cause of cancer; quantitative estimates of avoidable risk of cancer in the United
States.
J. Nat. Cancer Inst.
66
1981;
1191-1308
- 19
Dröge W., Eck H. P., Gmünder H., Mihm S..
Modulation of lymphocyte functions and immune responses by cysteine and cysteine derivates.
Am. J. Med.
91
1991;
140-144
- 20
Evoy, D.; Liebermann, M.D.; Fahey, T.J.; Daly, M. D., Liebermann M. D., Fahey T. J.,
Daly M..
Immunonutrtion. The role of arginine.
Nutrtion.
41
1988;
611-617
- 21
Fiala E. S., Staretz M. E., Pandya G. A., El-Bayoumy K., Hamilton S. R..
Inhibition of DANN cytosine methyltransferase by compreventive selenium compounds,
determindes b an improved assay for DANN cytosine methyltransferase and DANN cytosine
methylation.
Carcigonesis.
19
(4)
1998;
597-604
- 22
Grenz M..
Ernährung und Krebs.
Erfahrungsheilkunde.
2
1994;
82-85
- 23 Gröber U.. Orthomolekulare Medizin. Wissenschaftliche Verlagsgesellschaft Stuttgart;
2000
- 24
Grimble R. F., Grimble G. K..
Immunonutrtion: Role of sulfur amino accids, related amino accids, and polyamines.
Nutrtrion.
14
1998;
605-610
- 25 Hager E. D.. Komplementäre Onkologie. Adjuvante, additive, supportive Therapiekonzepte
für Klinik und Praxis. Forum-Med-Verlag Gesellschaft Gräfelfing; 1997
- 26
Hamers F. P. T., Brakkee J. H., Cavalletti E., Tedeschi M., Marmonti L., Pezzoni G..
Reduced Glutathione Protects against Cisplatin-induced Neurotoxicity in Rats: Neijt,
J.P.; Gispen, W.H..
Cancer Research.
53
1993;
544-549
- 27 Hu Y., Zhou M., Zhang Y., Zang B., Luo L., Xu P., Zhao Y., Zhao Y., Chen R.. The
protective role of selenium on the toxcitiy of cisplatin contained chemotherapy regimen
in cancer patients. The sixth international Symposium on Selenium in Biology and Medicine.
Peking; 1996
- 28 Hehr T., Bamberg M., Rodemann H. P.. Präklinische und klinische Relevanz der radioprotektiven
Wirkung von Natriumselenit. IV Dresdner Selensymposium am 15.05.-16.05 Landesärztekammer
Dresden; Abstract 1999
- 29
Imura N., Naganuma A., Satoh M., Koyama Y..
Depression of toxic effects of anticancer agents by selenium or pretreatment with
metallothionein inducers.
Sangyo Ika Daigaku Zasshi.
9
1987;
223-229
- 30
Iwata S., Hori T., Sato N., Ueda-Taniguchi Y., Yamabe I., Nakamura H., Masutani H.,
Yodoi J..
Thiol-mediated redox regulation of lymphocyte proliferation.
Journal of immunology.
152
1994;
5633
- 31
Jungi W. F..
Krebsprophylaxe mit Vitaminen und Spurenelementen?.
Münch Med Wschr..
134
1992;
275-277
- 32
Juretic A., Spagnoli G. C., Hörig H..
Glutamine requirements in the generation of lymphokine-activated killer cells.
Clin Nutr..
13
1994;
24
- 33
Kiremidjian-Schumacher L., Roy M., Wishi H. I., Cohen M. W., Stotzky G..
Supplementation with selenium and human immune cell functions. II. Effect on cytotoxic
lymphocytes and natural killer cells.
Biol Trace Elem Res.
41
1994;
115-127
- 34
Klein S. R., Koretz R. L..
Nutrition support in patients with cancer. What do the data really show?.
Nutr. Clin. Pract..
9
1994;
91-100
- 35
Klimberg V. S..
Glutamine supresses PGE2 synthesis and breath cancer growth.
J Surg Res.
63
1996;
293-297
- 36
Lanfear J., Fleming J., Wu L., Webster G., Harrison P. R..
The selenium metabolite selenodiglutathion induces p53 and apoptosis: relevance of
the chemopreventiveeffects of selenium?.
Carcigonesis.
15
1994;
1387-1392
- 37
Leone R., Fracasso M. E., Soresi E., Cimino G., Tedeschi M., Castoldi D., Monzani V.,
Colombi L., Usari T., Bernareggi A..
Influence of glutathione administration on the disposition of free and total platinum
in patients after administration of cisplatin.
Cancer Chemother Pharmacol.
29
1992;
385-390
- 38
Marktl W..
Mikronährstoffe in Krebsprävention.
Forsch Komplementärmed..
6
1999;
248-255
- 39 Martin M.. Labormedizin in der Naturheilkunde. Urban-Fischer München; 2002
- 40 Moos R. W.. Antioxidants against cancer. Equinox Press, Inc. 2002
- 41
Mihm S., Dröge W..
Intracellular glutathione level controls DNA binding activity of NFkß like proteines.
Immunobiology.
181
1990;
245-247
- 42
Mihm S., Ennen J., Pessagra U..
Inhibition of HiV-1 replication an NFkß activity by cysteine and cysteine derivates.
AIDS.
5
1991;
497-503
- 43
Milner J. A..
Effect of selenium on virally induced and transplantable tumor models.
Fed Proc.
44
1985;
2568-2572
- 44
Milner J. A., Hsu C. Y..
Inhibitory effects of selenium on the growth of L1210 Leukemic cells.
Cancer Res..
41
1982;
1652-1656
- 45
Muss C..
Immunologische Störungen des T-Zell-assoziierten Immunsystems durch Mangel an essentiellen
Spurenelementen Selen, Zink und Kupfer.
Zt. Erfahrungsheilkunde.
4
2002;
264-271
- 46
Palwicz Z., Zachara B. A., Trafilowska U., Maciag A., Marchaluk E., Nowicki A..
Blood Selenium Concentrations and Glutathione Peroxidase Activities in Patients with
Breast Cancer and with Advanced Gastrintestinal Cancer.
J. Trace Elem. Electrolytes health Dis.
5
1991;
275-277
- 47
Pereth A., Neve J., Desmedt J., Duchateau J., Dramaix M., Famaey J. P..
Lymphocyte response is enhanced by supplementation of elderly subjects with selenium
enriched yeast.
Am J Clin Nutr.
53
1991;
1323-1328
- 48
Perchellet J.- P., Abney N. L., Thomas R. M., Guislain Y. L., Perchellet E. M..
Effects of Combined Treatments with Selenium, Glutatione, and Vitamin E on Glutathione
Peroxidase Activity, Omithine Decarboxylase Induction, and Complete and Multistage
Carcinogenesis in Mouse Skin.
Cancer research.
15
1987;
477-485
- 49
Plaxe St., Freddo J., Kim S., Kirmani S., McClay E., Christen R., Braly P., Howell St..
Phase I Trial of Cisplatin in Combination with Glutathione.
Gynecology Oncology.
55
1994;
82-86
- 50
Psantakis D., Wedemayer N., Oevermann E., Krug F., Siegers C., Bruch H. P..
Blood Selenium and Glutathione Peroxidase Status in Patients with Colorectal Cancer.
Dis Colon Rectum.
41
1998;
328-335
- 51
Rabaast U..
Ernährungseinflüsse in der Entstehung und Prävention von Tumorerkrankungen.
Aktuelle Ernährungsmedizin.
17
1992;
215
- 52
Rayman M. P..
The importance of selenium to human health.
Lancet.
356
2000;
233-241
- 53
Reglin F..
Wer braucht eine Zinksubstitution?.
Praxistelegramm.
1
2000;
15-17
- 54
Rostkowska-Nadolska B., Pospiech L., Bochnia M..
Content of Trace Elements in Serum of Patients with Carcinoma of the Larynx.
Archivum Imumologiae et Therapie Expermentalis.
46
1999;
321-325
- 55 Schleicher U. M.. et al. .In-vitro-Strahlensensibilität verschiedener Zellen nach
Natriumselenit-Inkubation. DEGRO-Kongress Abstract 7.-10..11..1998 Nürnberg;
- 56 Schrauzer G. N.. Selen. Neue Entwicklungen aus Biologie, Biochemie und Medizin. Ambrosius
Barth Verlag, Hüthig Gmbh Heidelberg, Leipzig; 1998
- 57
Shklar C., Schwartz J., Trickler D., Cheverie S. R..
The effectiveness of a mixture of beta-carotene, alpha-tocopherol, glutathione, and
ascorbic acid for cancer prevention.
Nutr-Cancer.
20
(2)
1993;
145-51
- 58
Silk D. B. A..
Protein digestion and amino acid and peptide absorption.
Proceedings of the Nutrion Society.
44
1985;
63-72
- 59
Somfai-Relle S., Vistica B. P., Vistica D. T..
Reduktion der glutathionabhängigen Resistenz gegenüber Zytostatika.
Beitr. Onkol.
1984;
139-155
- 60 Stähelin H. B.. Krebserkrankungen und Ernährung. In: Ernährungsmedizin. Biesalski
(Hrsg.) Georg Thieme Verlag Stuttgart; 1999
- 61
Sundstrom H., Yrjanheikki E., Kauppila A..
Serum selenium in patients with ovari an cancer during and after therapy.
Carcinogenesis (United States).
5
1984;
731-734
- 62
Trickler D., Shklar G., Schwartz J..
Inihibition of oral carcinogenesis by glutathione.
Nutr-Cancer.
20
(2)
1993;
139-44
- 63
Tedeschi M., De Cesare A., Oriana S., Perego P., Silva A., Venturino P., Zunino F..
The role of glutathione in combination with cisplatin in the treatment of ovarian
cancer.
Cancer Treatment Reviews.
18
1991;
253-259
- 64
Tofanetti O., Cavalletti E., Besati A., Pratesi G., Pezzoni G., Zunino F..
Prevention of cyclophosphamide-induced urotoxicity by reduced glutathione and its
effect on acute toxicity and antitumor activity of the alkylating agent.
Cancer Chemother Pharmacol.
14
1985;
188-193
- 65 Uhlenbruck G., van Mil A.. Immunbiologische und andere Aspekte der Membranmodulation
durch Carnitin. Echo Verlag Köln; 1993
- 66
Ujiie S., Itoh K., Kikuchi H., Wakui A..
Serum selenium contents in cancer patients.
Gan To Kagaku Ryho.
4
1997;
401-405
- 67
Vince R., Wadd W. B..
Glyxolase inhibitors as potential anticancer agents.
Biochemical and Biophysical Research Communications.
35
1969;
5
- 68
Vinnars E., Fürst P., Hallgren B., Hermansson I. L., Josephson B..
The nutritive effect in man of non-essential amino accids infused intravenously. I.
Individual non-essential amino acids.
Acta Anaesth Scand..
14
1970;
147-172
- 69
Willet W. C..
Preddiagnostic serum selenium and risk of cancer.
Lancet (England).
2
1983;
130 (273)-134 (278)
- 70
Yoda Y., Nakazawa M., Abe T., Kawakami Z..
Prevention of Doxorubicin Myocardial Toxicity in Mice by Reduced Glutathione.
Cancer Research.
46
1986;
2551-2556
- 71
Yoshizawa K..
Selenium linked to lower prostate cancer risk.
Journal of the National Cancer Institut.
90
1998;
1219-24
- 72
Zucker R. M., Whittington K. B..
Glutathione mediated lysis of HL-60 cells.
Research Communications in Chemical Pathology and Pharmacolog.
39
(2)
1983;
- 73
Zunino, F.; Pratesi, G.; Micheloni, A.; Cavalletti, E.; Sala, F.; Tofanetti, O. F.,
Pratesi G., Micheloni A., Cavalletti E., Sala F., Tofanetti O..
Protective effect of reduced glutathione against cisplatin induced renal and systemic
toxicity and its influence on the therapeutic activity of the antitumor dnig.
Chem.-Biol. Interactions.
Elsevier Scientific Publishers Ireland Ltd.
70
1989;
89-101
Dr. Dr. med. Claus Muss
Ernährungsmediziner und Immunologe
Bahnhofstr.8
86150 Augsburg
Email: drclausmuss@aol.com
